Nuvalent

NUVL | NASDAQ | 0 Followers
$81.78 -0.35% -$0.28
Follow
Overview Metrics Financials
Loading...

Fair Price

$44.52
Overvalued by 14.7%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Nuvalent is a biotechnology company focused on developing targeted therapies for the treatment of advanced cancers. The company uses advanced technologies to create specific drugs that target molecular mechanisms within cancer cells, increasing treatment effectiveness and minimizing side effects. Nuvalent focuses on developing therapeutics for cancers with specific genetic mutations, such as lung cancer, and strives to provide new treatment options for patients.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade